# MitoQ for the Treatment of Metabolic Dysfunction in Asthma

> **NCT04026711** · PHASE1 · COMPLETED · sponsor: **University of Vermont** · enrollment: 47 (actual)

## Conditions studied

- Asthma
- Obesity

## Interventions

- **DRUG:** Mitoquinol
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04026711
- **Lead sponsor:** University of Vermont
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2024-03-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2025-12-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04026711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04026711, "MitoQ for the Treatment of Metabolic Dysfunction in Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04026711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*